Fibrous cortical defects (FCDs) are benign lesions that are bony in structure and are a type of fibroxanthoma, histologically similar to larger non-ossifying fibroma (NOF). Non-ossifying fibroma is a part which is related to intramedullary segment. Different terms such as fibroxanthoma, non-osteogenic fibroma, and benign fibrous histiocytoma are used for fibrous cortical defects. FCDs usually does not causes any symptoms except pain. However, if the pain increases to half the bone’s diameter, it can cause severe pain and increase the risk of sustaining bone fracture. The most prone sites of fibrous cortical defects (FCD) incorporate distal femur, tibia and among these most of them show various imperfections. Most of the times FCDs occur when lesions created ossify and get convert into the dense areas of bone, sometimes these lesions may enlarge and increase the problem. The occurrence of fibrous cortical defects is around 40% children and is quite common in young adults. FCD is also known as non-solidifying fibroma (NOF), a term which is regularly utilized when the tumor or lesion is large and expands upon the focal part of the bone called the medullary canal.

FCDs are usually diagnosed through an X-ray. However, if it becomes severe, radiology can be used to determine the growth of the lesion. FCD lesions are benign and normally do not require any treatment. These lesions often go away on their own without surgery as soon as the child starts to grow, they do not turn into cancer. However, if these lesions increase and do not go away, treatments such as casting are required during surgery to prevent metaphyseal injuries. If still FCD does not get recovered, curettage and bone grafting may be required.

FCDs require medical therapy to treat pediatric pathologic fracture to avoid any further injury during surgery. The surgical procedure involves exposing the lesion to curette the tumor. Furthermore, allografting or auto grafting can be performed, depending on the size of the lesion. Prognosis is good and rapid in patients undergoing curettage and bone grafting.

Identification of FCDs involve plain X-rays, CT scan, MRI scan, and whole-body scans.

Curettage involves scraping out the tumor from the bone. If the pathological condition is severe i.e. if the medical reports indicate to fibroblasts in fibrous stroma, giant cells, and lack of bone development at the FCD site, bone grafting surgery is likely to be performed. Bone grafting surgery involves auto grafting procedure which is performed using a bone from the child’s own body. The other alternatives available are allografting procedure (bone from another person’s body), grafting using cement, or some bone substitute, which is chemically prepared in the laboratory.

Furthermore, sometimes some chemicals are used to put in the hole during the surgery. These chemicals prevent the tumor from reappearing in the future. In severe cases, if the fracture is unstable, due to presence of large lesion, plate and screws can be used to stabilize the bone. The chances of the reoccurrence of nonossifying fibroma after surgery are low.

Key players operating in the global fibrous cortical defect treatment market include B. Braun, Surgival, Straumann, Jeil Medical, and DePuy Synthes.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

.